Special Diabetes Program for Indians (SDPI) Diabetes Prevention and Healthy Heart Initiative

 

The Indian Health Service (IHS) announces a new initiative under the Special Diabetes Program for Indians (SDPI). This funding mechanism is a competitive cooperative agreement program that will provide funding to selected SDPI grantees for a demonstration project to implement and evaluate defined activities in one of two areas (primary prevention of diabetes or prevention of cardiovascular disease in people with diabetes).

Deleted 04/02/2020 (Archived.) 93.442 Agency: Department of Health and Human Services
Office: Indian Health Service Cooperative Agreements Not Applicable. Balanced Budget Act of 1997, Public Law 105-33; Medicare Improvements for Patients and Providers Act of 2008, Public Law 110-275; Medicare, Medicaid, and SCHIP Extension Act of 2007, Public Law 110-173; Reauthorization of SDPI 2002, Public Law 107-360; Consolidated Appropriations Act of 2001, Public Law 106-554. Applicants eligible to receive an award under this announcement are SDPI grant recipients. The applicant must be one of the following entities: IHS hospital or clinic, federally recognized Tribes, Title V Urban Indian Health Programs or consortia of any of the above. A SDPI grant recipient can apply only once as a single entity or as part of consortium. An application submitted by consortium of SDPI grant recipients must be submitted by one of the SDPI grant recipients sanctioned as the principal applicant. A letter of support must be included in the application from each SDPI grantee the principle applicant is representing. The letter must specifically state that the principal applicant is officially representing that SDPI grantee in this application. Applicants for consortium who do not submit these letters of support at the time of the application receipt date will not be reviewed and are ineligible for the award. Smaller applicants are encouraged to apply as part of consortium, especially their diabetes registry is less than 250. Applicants are strongly encouraged to establish eligibility of their proposed applications prior to submission. Inquires about eligibility should be addressed to Gordon Quam, SDPI Demonstration Projects Grant Project Officer, IHS Division of Diabetes Treatment and Prevention at 505-248-4182; email to diabetesprogram@ihs.gov. Applicants that are not SDPI grant recipients are not eligible. Non-profit tribal organizations or national/area health boards are not eligible, consistent with recent tribal consultation on this issue. Applications that do not meet these eligibility requirements will be returned to the applicant without further review. American Indians and Alaska Natives will be the ultimate beneficiaries of the funded demonstration projects through either prevention or direct treatment services. Costs will be determined in accordance with OMB Circular Circular No. A-122, "Cost Principles for Non-Profit Organizations.". 2 CFR 200, Subpart E - Cost Principles applies to this program. Preapplication coordination is required. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Applications can be found at http://www.grants.gov. Applications will also be available on request from the IHS Division of Diabetes Treatment and Prevention at the following address: 5300 Homestead Road, NE, Albuquerque, NM 87110. Telephone: (505) 248-4182, fax 505-248-4188, email address: diabetesprogram@ihs.gov. The application will be posted on the IHS Division of Diabetes Treatment and Prevention web site at www.diabetes.ihs.gov and on the HHS Grants web site at http://www.grants.gov. Applicants may submit one application for one or both demonstration projects. A separate application is required for each demonstration project. Applicants will be funded for only one project (primary prevention of diabetes or prevention of cardiovascular disease in people with diabetes).

Tribal Approval of Application/Letter of Support: It is the policy of the IHS that all projects involving AIAN tribes be approved by the Tribal governments with jurisdiction. Therefore, the following documentation is required as part of this application: 1) For federally recognized Indian tribe - a resolution of support from the Tribal government must be a part of the application. Applications that involve more than one Indian tribe must include resolutions of support from all participating tribes. 2) For an eligible consortium of tribes - a resolution of support from each tribe of the consortium must be included. 3) For Title V Urban Indian Health Programs - a letter of support from the program's board must be included. 4) For IHS hospitals or clinics - a letter of support from the Service Unit Director or Chief Executive Officer must be included. 5) For all applicants - letters of support from all partners and collaborating entities.

The preferred method for receipt of applications is electronic submission through Grants.gov. However, should any technical problems arise regarding the submission, please contact Grants.gov Customer Support at 1-800-518-4726 or support@grants.gov. The Contact Center is open 24 hours a day, 7 days a week (except Federal holidays). If you require additional assistance please contact Tammy Bagley, Grants Policy Officer; Telephone: (301) 443-5204 at least ten days prior to the application deadline. To submit an application electronically, please use the http://www.Grants.gov apply site. Download a copy of the application package, on the Grants.gov website, complete it offline and then upload and submit the application via the Grants.gov site. You may not e-mail an electronic copy of a grant application to us. Upon receipt, IHS will administratively review applications by completeness and responsiveness. Applications that are incomplete, non-responsive to this RFA, do not meet eligibility criteria or do not follow the guidelines of the SF 424 will be returned to the applicant without further consideration. Applications will be evaluated for technical merit by appropriate peer review groups convened by the IHS National Diabetes Program in accordance with established criteria. Applicants will only be eligible to receive one award for funding in one area (i.e. primary prevention of diabetes or prevention of cardiovascular disease in people with diabetes. Priorities for funding will be based on the technical merit of the application, the assessed potential of the applicant and the likelihood of the applicant to successfully implement the defined interventions. Awards will be made only to organizations with financial management systems and management capabilities that are acceptable under PHS Policy. Awards will be administered under the PHS Grants Policy Statement. Awards will be subject to the availability of funds and grants will be administered in accordance with applicable Office of Management and Budget (OMB) Circulars, Department of Health and Human Services grant regulations at 45 CFR Parts 74 and 92, the Public Health Service Grants Policy Statement and other applicable IHS polices and procedures such as the regulations governing protection of human subjects at 45 CFR Part 46. Grants Management will not award a grant without an approved application in conformance with regulatory and policy requirements and which describes the purpose and scope of the project to be funded. When the application is approved for funding, the Grants Management Office will prepare a Notice of Grant Award with special terms and conditions binding upon the award and refer to all general terms applicable to the award. Contact the headquarters or regional office, as appropriate, for application deadlines. From 60 to 90 days. The anticipated date for the announcement of selectees is 60 days after the application due date. Not Applicable. This funding will be awarded as a cooperative agreement, renewable annually for up to one additional year (FY 2011). The IHS will determine if cooperative agreements are renewable after these 2 years depending on funding levels and congressional actions. Not Applicable. Funds (including direct costs and allowable indirect costs) may be used only for expenses clearly related and necessary to carry out approved activities that will support the implementation and evaluation of demonstration projects under this competitive grant program. Program reports are not applicable. Grantees will be required to submit quarterly Federal Financial Report (SF-425 or FFR) to the Division of Payment Management Branch. Progress reports are required annually, semi-annually or quarterly depending on the time lines set by the IHS program. A final progress report is due 90 days after the end of each budget period and at the end of the final project period. Grantees will be required to submit quarterly Federal Financial Report (SF-425 or FFR) to the Division of Payment Management Branch. IHS grants are monitored by the Division of Grants Management for financial compliance and by the IHS Program Staff for programmatic compliance. In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials. All records of the grant must be retained for 3 years after submission of the final expenditure report. If questions remain, such as those resulting from an audit, pertinent records must be kept until the matter is resolved. The Secretary, the Inspector General of the Department of the Health and Human Services, and the Comptroller General of the United States or any of their authorized representatives shall have the right to access all records, report, books, document, papers or other records of the grantee, contractor, or subcontractor or of any entity pertinent to the DHHS grant in order to make audits, examinations, excerpts and transcripts. Statutory formulas are not applicable to this program.
Matching requirements are not applicable to this program.
MOE requirements are not applicable to this program. Assistance is available during the stated Project Periods. Method of awarding/releasing assistance: quarterly. See Regional Agency Offices. Program Contact: IHS Division of Diabetes Treatment and Prevention, 801 Thompson Avenue, Suite 300, Rockville, MD 20852; e-mail IHSDDTPSDPICommunity@ihs.gov; Telephone: 1-844-447-3387.

Grants Management Contact: Ms. Tammy Bagley, Acting Director, Division of Grants Management, Indian Health Service, 801 Thompson Avenue, Suite TMP 360, Rockville, MD 20852. Telephone: (301) 443-5204, Fax (301) 443-9602. Use the same number for FTS. Grants Policy Office 801 Thompson Avenue, Suite TMP 360, Rockville, Maryland 20852 Email: grantspolicy@ihs.gov Phone: 301-443-5204 http://www.ihs.gov 75-0390-0-1-551. (Cooperative Agreements) FY 14 $23,182,200; FY 15 est $23,182,200; and FY 16 est $0 $137,500 - $397,000; average award is $340,915. Not Applicable. Not Applicable.